FrancophonIA/ELRC3.0 huggingface dataset:
English: Medicinal product subject to medical prescription.
Croatian: 14. NAČIN IZDAVANJA LIJEKA Lijek se izdaje na recept.
English: Reproductive system and breast disorders Not known:
Croatian: Poremećaji bubrega i mokraćnog sustava Nepoznato:
English: Male patients should be aware of the possible male-mediated foetal toxicity.
Croatian: Bolesnici muškog spola moraju biti svjesni da mogu biti posrednici u pojavi fetalne toksičnosti.
English: White to almost white, round film-coated tablet, imprinted with ZBN on one side.
Croatian: Bijela do gotovo bijela, okrugla filmom obložena tableta s utisnutom oznakom ZBN na jednoj strani.
English: Your doctor will carry out blood tests at regular intervals, before and during treatment with Leflunomide Zentiva, to monitor your blood cells and liver.
Croatian: Prije i za vrijeme liječenja lijekom Leflunomide Zentiva liječnik će Vas u redovitim razmacima slati na krvne pretrage radi kontrole krvnih stanica i jetre.
English: If the patient is already receiving nonsteroidal anti-inflammatory drugs (NSAIDs) and/or corticosteroids, these may be continued after starting leflunomide.
Croatian: Bolesnici koji već uzimaju nesteroidne protuupalne lijekove (NSAIL) i/ili kortikosteroide mogu ih nastaviti uzimati nakon uvođenja leflunomida u liječenje.
English: Colestyramine 8 g is administered 3 times daily.
Croatian: Daje se 8 g kolestiramina 3 puta na dan.
English: The relevance of the findings in mice relative to the clinical use of leflunomide is uncertain.
Croatian: Nije sigurno jesu li ti nalazi u miševa značajni za kliničku primjenu leflunomida.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS NAME OF THE MEDICINAL PRODUCT
Croatian: PODACI KOJE MORA NAJMANJE SADRŽAVATI BLISTER ILI STRIP
English: White to almost white, round film-coated tablet, imprinted with ZBP on one side.
Croatian: Bijela do gotovo bijela, okrugla filmom obložena tableta s utisnutom oznakom ZBP na jednoj strani.
English: The most frequently reported adverse effects with leflunomide are: mild increase in blood pressure, leucopenia, paraesthesia, headache, dizziness, diarrhoea, nausea, vomiting, oral mucosal disorders (e.g. aphthous stomatitis, mouth ulceration), abdominal pain, increased hair loss, eczema, rash (including maculo-papular rash), pruritus, dry skin, tenosynovitis, CPK increased, anorexia, weight loss (usually insignificant), asthenia, mild allergic reactions and elevation of liver parameters (transaminases (especially ALT), less often gamma-GT, alkaline phosphatise, bilirubin)).
Croatian: Najčešće zabilježene nuspojave tijekom primjene leflunomida su: blagi porast krvnog tlaka, leukopenija, parestezija, glavobolja, omaglica, proljev, mučnina, povraćanje, poremećaji sluznice usne šupljine (npr. aftozni stomatitis, ulceracije u ustima), bol u abdomenu, pojačani gubitak kose, ekcem, osip (uključujući makulopapularni osip), pruritus, suha koža, tenosinovitis, povećanje CPK, anoreksija, gubitak težine (obično beznačajan), astenija, blage alergijske reakcije i porast jetrenih parametara (transaminaze (osobito ALT), manje često gama-GT, alkalna fosfataza, bilirubin).
English: The efficacy of Leflunomide Zentiva was demonstrated in one controlled, randomised, double blind study 3L01 in 188 patients with psoriatic arthritis, treated at 20 mg/day.
Croatian: Djelotvornost lijeka Leflunomide Zentiva u liječenju psorijatičnog artritisa pokazala se u jednom kontroliranom, randomiziranom, dvostruko slijepom ispitivanju 3L01 na 188 bolesnika s psorijatičnim artritisom.
English: Together with ALT, a complete blood cell count, including differential white blood cell count and platelets, must be performed before start of leflunomide treatment as well as every 2 weeks for the first 6 months of treatment and every 8 weeks thereafter.
Croatian: Uz određivanje vrijednosti ALT, prije početka liječenja leflunomidom valja načiniti kompletnu krvnu sliku s diferencijalnom bijelom krvnom slikom i trombocitima, a zatim to ponavljati svaka 2 tjedna u prvih 6 mjeseci liječenja i nakon toga svakih 8 tjedana.
English: - zidovudine for HIV infection - rosuvastatin, simvastatin, atorvastatin, pravastatin for hypercholesterolemia (high cholesterol) - sulfasalazine for inflammatory bowel disease or rheumatoid arthritis - a medicine called colestyramine (used to reduce high cholesterol) or activated charcoal as these medicines can reduce the amount of Leflunomide Zentiva which is absorbed by the body.
Croatian: - indometacin, ketoprofen za liječenje boli ili upale - furosemid za liječenje bolesti srca (diuretik, tableta za vodu) - zidovudin za liječenje HIV infekcije - rozuvastatin, simvastatin, atorvastatin, pravastatin za liječenje hiperkolesterolemije (povišeni kolesterol) - sulfasalazin za liječenje upalne bolesti crijeva ili reumatoidnog artritisa - lijek koji se zove kolestiramin (primjenjuje se za snižavanje visoke razine kolesterola) ili aktivni ugljen, jer ti lijekovi mogu smanjiti količinu lijeka Leflunomide Zentiva koju Vaše tijelo apsorbira.
English: There was an increase in mean ethinylestradiol Cmax and AUC0-24 (1.58- and 1.54-fold, respectively) and levonorgestrel Cmax and AUC0-24 (1.33- and 1.41-fold, respectively) following repeated doses of
Croatian: Zabilježeno je povećanje prosječne Cmax i AUC0-24 (1,58 odnosno 1,54 puta) za etinilestradiol i povećanje prosječne Cmax i AUC0-24 (1,33 odnosno 1,41 puta) za levonorgestrel, nakon ponovljenih doza A771726.
English: There was an increase in mean repaglinide Cmax and AUC (1.7- and 2.4-fold, respectively), following repeated doses of A771726, suggesting that A771726 is an inhibitor of CYP2C8 in vivo.
Croatian: Zabilježeno je povećanje prosječne Cmax i AUC (1,7 odnosno 2,4 puta) za repaglinid, nakon ponovljenih doza A771726, što ukazuje da je A771726 inhibitor CYP2C8 in vivo.
English: Since the active metabolite of leflunomide, A771726, is highly protein bound and cleared via hepatic metabolism and biliary secretion, plasma levels of A771726 are expected to be increased in patients with hypoproteinaemia.
Croatian: Kako se aktivni metabolit leflunomida, A771726, snažno veže za proteine u plazmi i uklanja metaboliziranjem u jetri i sekrecijom putem žuči, u bolesnika s hipoproteinemijom očekuje se povećanje koncentracije A771726 u plazmi.
English: The procedure may be repeated as clinically necessary.
Croatian: Ako je klinički neophodno, postupak se može ponoviti.
English: Leflunomide 20 mg/day was significantly superior to placebo in reducing the symptoms of arthritis in patients with psoriatic arthritis: the PsARC (Psoriatic Arthritis treatment Response Criteria) responders were 59% in the leflunomide group and 29.7% in the placebo group by 6 months (p<0.0001).
Croatian: Psoriatic Arthritis Treatment Response Criteria, PsARC) na liječenje odgovorilo 59% bolesnika u skupini liječenoj leflunomidom i 29,7% bolesnika u skupini koja je primala placebo (p< 0,0001).
English: Study MN301 randomised 358 subjects with active rheumatoid arthritis to leflunomide 20 mg/day (n=133), sulphasalazine 2 g/day (n=133), or placebo (n=92).
Croatian: U ispitivanju MN301, 358 randomiziranih bolesnika s aktivnim reumatoidnim artritisom uzimalo je leflunomid 20 mg/dan (n=133), sulfasalazin 2 g/dan (n=133) ili placebo (n=92).
English: Age older than 60 years, concomitant neurotoxic medications, and diabetes may increase the risk for peripheral neuropathy.
Croatian: Rizik od periferne neuropatije može biti povećan u bolesnika starijih od 60 godina, onih koji istodobno uzimaju neurotoksične lijekove ili u bolesnika s dijabetesom.
English: A randomised, double-blind, parallel-group non-inferiority study compared the relative efficacy of two different daily maintenance doses of leflunomide, 10 mg and 20 mg. From the results it can be concluded that efficacy results of the 20 mg maintenance dose were more favourable, on the other hand, the safety results favoured the 10 mg daily maintenance dose.
Croatian: Randomiziranim, dvostruko slijepim, neinferiornim ispitivanjem paralelnih skupina uspoređivala se relativna djelotvornost dviju različitih dnevnih doza održavanja leflunomida, odnosno 10 i 20 mg.
English: Washout procedure
Croatian: Postupak ispiranja („washout“)
English: There are no specific data on the risk of male-mediated foetal toxicity.
Croatian: Nema specifičnih podataka da bi liječenje muškaraca moglo uzrokovati pojavu fetalne toksičnosti.
English: If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Croatian: U slučaju bilo kakvih pitanja u vezi s primjenom ovog lijeka, obratite se svom liječniku, ljekarniku ili medicinskoj sestri.
English: Imprint on one side: ZBP
Croatian: Utisnuta oznaka na jednoj strani: ZBP.
English: All patients received folate 1 mg bid.
Croatian: Svi bolesnici primali su 1 mg folata dvaput na dan.
English: The patient must be advised that if there is any delay in onset of menses or any other reason to suspect pregnancy, they must notify the physician immediately for pregnancy testing, and if positive, the physician and patient must discuss the risk to the pregnancy.
Croatian: Bolesnice treba savjetovati da u slučaju kašnjenja menstruacije ili sumnje na trudnoću obavezno odmah obavijeste liječnika zbog provođenja testa na trudnoću.
English: • Pregnant women, or women of childbearing potential who are not using reliable contraception during treatment with leflunomide and thereafter as long as the plasma levels of the active metabolite are above 0.02 mg/L (see section 4.6).
Croatian: • Trudnice i žene reproduktivne dobi koje ne koriste učinkovitu kontracepciju tijekom liječenja leflunomidom i nakon njega, sve dok je koncentracija aktivnog metabolita u plazmi veća od
English: In such cases re-exposure to leflunomide is contraindicated (see section 4.3).
Croatian: U tim je slučajevima neophodno potpuno ispiranje lijeka, a ponovno uzimanje leflunomida je kontraindicirano (vidjeti dio 4.3).
English: Study MN302 randomised 999 subjects with active rheumatoid arthritis to leflunomide 20 mg/day (n=501) or methotrexate at 7.5 mg/week increasing to 15 mg/week (n=498).
Croatian: U ispitivanju MN302 bilo je 999 randomiziranih bolesnika s aktivnim reumatoidnim artritisom koji su primali leflunomid 20 mg/dan (n=501) ili metotreksat 7,5 mg/tjedan, s povećanjem doze na 15 mg/tjedan (n=498).
English: The phase II trial, study YU203, randomised 402 subjects with active rheumatoid arthritis to placebo (n=102), leflunomide 5 mg (n=95), 10 mg (n=101) or 25 mg/day (n=104).
Croatian: U ispitivanju faze II, YU203, 402 randomizirana bolesnika s aktivnim reumatoidnim artritisom dobivala su placebo (n=102), leflunomid 5 mg/dan (n=95), 10 mg/dan (n=101) ili 25 mg/dan (n=104).
English: Study US301 randomised 482 subjects with active rheumatoid arthritis to leflunomide 20 mg/day (n=182), methotrexate 7.5 mg/week increasing to 15 mg/week (n=182), or placebo (n=118).
Croatian: U ispitivanju US301 482 randomizirana bolesnika s aktivnim reumatoidnim artritisom primala su leflunomid 20 mg/dan (n=182), metotreksat 7,5 mg/tjedan, s povećanjem doze na 15 mg/tjedan (n=182), ili placebo (n=118).
English: Zentiva Portugal, Lda Tel: +351210601360
Croatian: Zentiva Portugal, Lda Tel: +351210601360 PV-Portugal@zentiva.com
English: The extensive protein binding of A771726 could lead to displacement of other highly-bound drugs.
Croatian: Ekstenzivnim vezanjem za proteine A771726 može istisnuti ostale lijekove koji se u velikoj mjeri vežu za proteine plazme.
English: After stopping treatment with leflunomide:
Croatian: Nakon prekida uzimanja leflunomida treba primijeniti:
English: You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
Croatian: Nuspojave možete prijaviti izravno putem nacionalnog sustava za prijavu nuspojava navedenog u Dodatku V.
English: Other side effects such as kidney failure, a decrease in the levels of uric acid in your blood, pulmonary hypertension, male infertility (which is reversible once treatment with this medicine is stopped), cutaneous lupus (characterized by rash/erythema on skin areas that are exposed to light), psoriasis (new or worsening) and DRESS may also occur with an unknown frequency.
Croatian: Također se mogu javiti druge nuspojave, poput zatajenja bubrega, smanjene koncentracije mokraćne kiseline u krvi, plućne hipertenzije, muške neplodnosti (koja se povlači nakon prestanka primjene ovoga lijeka), kožnog lupusa (karakteriziran osipom/crvenilom na područjima kože izloženima svjetlu), psorijaze (novonastala psorijaza ili pogoršanje psorijaze) i reakcije na lijek s eozinofilijom i sistemskim simptomima (DRESS), ali je njihova učestalost nepoznata.
English: How to take Leflunomide Zentiva
Croatian: Kako uzimati lijek Leflunomide Zentiva
English: Uncommon: taste disturbances
Croatian: Manje često: ruptura tetive
English: pulmonary hypertension Gastrointestinal disorders Common:
Croatian: plućna hipertenzija Poremećaji probavnog sustava Često:
English: Neoplasms benign, malignant and unspecified (incl.
Croatian: Dobroćudne, zloćudne i nespecificirane novotvorine (uključujući ciste i polipe)
English: Uncommon: anaemia, mild thrombocytopenia (platelets <100 G/L) Rare:
Croatian: Manje često: anemija, blaga trombocitopenija (trombociti < 100 g/l).
English: Leflunomide Zentiva 100 mg film-coated tablets are white to almost white and round.
Croatian: Kako Leflunomide Zentiva izgleda i sadržaj pakiranja Leflunomide Zentiva 100 mg filmom obložene tablete su bijele do gotovo bijele i okrugle.
English: - a marked decrease of some white blood cells (agranulocytosis), - severe and potentially severe allergic reactions, - inflammation of the small vessels (vasculitis, including cutaneous necrotizing vasculitis), - inflammation of the pancreas (pancreatitis), - severe liver injury such as liver failure or necrosis which may be fatal, - severe sometimes life-threatening reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme).
Croatian: Vrlo rijetke nuspojave (mogu se javiti u manje od 1 na 10 000 osoba): - izrazito smanjenje broja određenih bijelih krvnih stanica (agranulocitoza), - teške i potencijalno teške alergijske reakcije, - upala malih krvnih žila (vaskulitis, uključujući kožni nekrotizirajući vaskulitis), - upala gušterače (pankreatitis), - teško oštećenje jetre, poput zatajenja jetre ili nekroze, koje može biti opasno po život, - teške reakcije koje ponekad mogu biti opasne po život (Stevens-Johnsonov sindrom, toksična epidermalna nekroliza, multiformni eritem).
English: Excipients with known effect Each tablet contains 78 mg of lactose monohydrate.
Croatian: Pomoćne tvari s poznatim učinkom Jedna tableta sadrži 78 mg laktoze hidrata.
English: Leflunomide Zentiva 10 mg film-coated tablets are white to almost white and round.
Croatian: Kako Leflunomide Zentiva izgleda i sadržaj pakiranja Leflunomide Zentiva 10 mg filmom obložene tablete su bijele do gotovo bijele i okrugle.
English: In the phase III trials, the ACR response rates for leflunomide 20 mg/day versus placebo were 54.6% versus 28.6% (study MN301), and 49.4% versus 26.3% (study US301).After 12 months with active treatment, the ACR response rates in leflunomide patients were 52.3% (studies MN301/303), 50.5% (study MN302) and 49.4% (study US301), compared to 53.8% (studies MN301/303) in sulphasalazine patients, 64.8% (study MN302), and 43.9% (study US301) in methotrexate patients.
Croatian: Nakon 12 mjeseci aktivnog liječenja stopa odgovora prema ACRu u bolesnika koji su primali leflunomid bila je 52,3% (ispitivanja MN301/303), 50,5% (ispitivanje MN302) i 49,4% (ispitivanje US301) u usporedbi s 53,8% (ispitivanja MN301/303) u bolesnika koji su primali sulfasalazin te 64,8% (ispitivanje MN302) i 43,9% (ispitivanje US301) u bolesnika koji su primali metotreksat.
English: 30 film-coated tablets 50 film-coated tablets 100 film-coated tablets
Croatian: OBLIK I SADRŽAJ 30 filmom obloženih tableta 50 filmom obloženih tableta 100 filmom obloženih tableta
English: Tél: +33 (0) 800 089 219 PV-France@zentiva.com
Croatian: Zentiva France Tél: +33 (0) 800 089 219 PV-France@zentiva.com
English: Breast-feeding women must, therefore, not receive leflunomide.
Croatian: Dojilje, stoga, ne smiju uzimati leflunomid.
English: Excipients with known effect Each tablet contains 72 mg of lactose monohydrate.
Croatian: Pomoćne tvari s poznatim učinkom Jedna tableta sadrži 72 mg laktoze hidrata.
English: Pregnancy must be excluded before start of treatment with leflunomide.
Croatian: Prije liječenja leflunomidom mora se isključiti trudnoća.
English: This is especially important if you are taking: - other medicines for rheumatoid arthritis such as antimalarials (e.g. chloroquine and hydroxychloroquine), intramuscular or oral gold, D-penicillamine, azathioprine and other immunosuppressive medicines (e.g. methotrexate) as these combinations are not advisable, - warfarin and other oral medicines used to thin the blood, as monitoring is necessary to reduce the risk of side effects of this medicine - teriflunomide for multiple sclerosis - repaglinide, pioglitazone, nateglinide, or rosiglitazone for diabetes - daunorubicin, doxorubicin, paclitaxel, or topotecan for cancer - duloxetine for depression, urinary incontinence or in kidney disease in diabetics - alosetron for the management of severe diarrhoea - theophylline for asthma - tizanidine, a muscle relaxant - oral contraceptives (containing ethinylestradiol and levonorgestrel) - cefaclor, benzylpenicillin (penicillin G), ciprofloxacin for infections - indomethacin, ketoprofen for pain or inflammation - furosemide for heart disease (diuretic, water pill)
Croatian: azatioprina i drugih imunosupresivnih lijekova (npr. metotreksat), jer se ne preporučuje istodobna primjena tih lijekova, - varfarin i druge oralne lijekove koji se koriste za razrjeđivanje krvi, jer je potrebno praćenje kako bi se smanjio rizik od nuspojava tih lijekova - teriflunomid za liječenje multiple skleroze - repaglinid, pioglitazon, nateglinid ili roziglitazon za liječenje šećerne bolesti - daunorubicin, doksorubicin, paklitaksel ili topotekan za liječenje raka - duloksetin za liječenje depresije, nesposobnosti zadržavanja mokraće ili bolesti bubrega u oboljelih od šećerne bolesti - alosetron za liječenje teškog proljeva - teofilin za liječenje astme - tizanidin, lijek za opuštanje mišića - oralni lijekovi za sprječavanje trudnoće (koji sadrže etinilestradiol i levonorgestrel) - cefaklor, benzilpenicilin (penicilin G), ciprofloksacin, za liječenje infekcija
English: Musculoskeletal and connective tissue disorders Common:
Croatian: Poremećaji mišićno-koštanog sustava i vezivnog tkiva Često:
English: Methotrexate
Croatian: Cijepljenje
English: Yellowish to ochre and triangular film-coated tablet, imprinted with ZBO on one side.
Croatian: Žućkasta do oker filmom obložena tableta u obliku trokuta, s utisnutom oznakom ZBO na jednoj strani.
English: • In rheumatoid arthritis: leflunomide therapy is usually started with a loading dose of 100 mg once daily for 3 days.
Croatian: • U bolesnika s reumatoidnim artritisom: terapija leflunomidom započinje primjenom udarne doze od 100 mg jedanput na dan tijekom 3 dana.
English: - a decrease in the number of red blood cells (anaemia) and a decrease in the number of blood platelets (thrombocytopenia), - a decrease in the levels of potassium in the blood, - anxiety, - taste disturbances, - urticaria (nettle rash), - tendon rupture, - an increase in the levels of fat in the blood (cholesterol and triglycerides), - a decrease in the levels of phosphate in the blood.
Croatian: Manje česte nuspojave (mogu se javiti u manje od 1 na 100 osoba): - smanjen broj crvenih krvnih stanica (anemija) i smanjen broj krvnih pločica (trombocitopenija), - smanjenje koncentracije kalija u krvi, - tjeskoba, - poremećaji okusa, - urtikarija (koprivnjača), - puknuće tetive, - povećanje razine masnoća u krvi (kolesterol i trigliceridi), - smanjenje razine fosfata u krvi.
English: • In psoriatic arthritis: leflunomide therapy is started with a loading dose of 100 mg once daily for 3 days.
Croatian: • U bolesnika s psorijatičnim artritisom: liječenje leflunomidom započinje primjenom udarne doze od 100 mg jedanput na dan tijekom 3 dana.
English: The concentration may be expected to decrease below 0.02 mg/L about 2 years after stopping the treatment with leflunomide.
Croatian: Smanjenje koncentracije A771726 u plazmi na razinu nižu od 0,02 mg/l očekuje se približno 2 godine nakon prekida liječenja leflunomidom.
English: agranulocytosis
Croatian: hipouricemija
English: MANUFACTURER RESPONSIBLE FOR BATCH RELEASE
Croatian: PROIZVOĐAČ ODGOVORAN ZA PUŠTANJE SERIJE LIJEKA U PROMET
English: MN301/303) in sulphasalazine patients, 64.8% (study MN302), and 43.9% (study US301) in methotrexate patients.
Croatian: MN302) i 49,4% (ispitivanje US301) u usporedbi s 53,8% (ispitivanja MN301/303) u bolesnika koji su primali sulfasalazin te 64,8% (ispitivanje MN302) i 43,9% (ispitivanje US301) u bolesnika koji su primali metotreksat.
English: colitis including microscopic colitis such as lymphocytic colitis, collagenous colitis, diarrhoea, nausea, vomiting, oral mucosal disorders (e.g., aphthous stomatitis, mouth ulceration), abdominal pain
Croatian: kolitis, uključujući mikroskopski kolitis poput limfocitnog kolitisa, kolagenog kolitisa, proljev, mučnina, povraćanje, poremećaji sluznice usne šupljine (npr. aftozni stomatitis, ulceracije u ustima), bol u abdomenu Manje često: poremećaji okusa
English: Certain vaccinations should not be given while taking Leflunomide Zentiva, and for a certain amount of time after stopping treatment.
Croatian: Za vrijeme uzimanja lijeka Leflunomide Zentiva, kao i određeno vrijeme nakon prekida liječenja, ne smije se provoditi cijepljenje određenim cjepivima.
English: All elevations resolved 2 with continuation of both medicinal products and 3 after discontinuation of leflunomide.
Croatian: Sve su se povišene vrijednosti smanjile, u 2 bolesnika koji su nastavili istodobno uzimati oba lijeka i u 3 bolesnika koji su prekinuli uzimati leflunomid.
English: Pack size: 3 film-coated tablets.
Croatian: Veličina pakiranja: 3 filmom obložene tablete
English: How to store Leflunomide Zentiva
Croatian: Kako čuvati lijek Leflunomide Zentiva
English: In either case the A771726 plasma concentration is then measured for the first time.
Croatian: U oba se slučaja tek tada prvi put mjeri koncentracija A771726 u plazmi.
English: The active metabolite A771726 is extensively protein bound and cleared via hepatic metabolism and biliary secretion.
Croatian: Aktivni metabolit A771726 ekstenzivno se veže za proteine u plazmi, a uklanja se jetrenim metabolizmom te izlučuje putem žuči.
English: • Patients with significantly impaired bone marrow function or significant anaemia, leucopenia, neutropenia or thrombocytopenia due to causes other than rheumatoid or psoriatic arthritis.
Croatian: • Bolesnici sa značajno oštećenom funkcijom koštane srži ili izraženom anemijom, leukopenijom,
English: - The other ingredients are: maize starch, povidone (E1201), crospovidone (E1202), silica colloidal anhydrous, magnesium stearate (E470b), and lactose monohydrate in the tablet core, as well as talc (E553b), hypromellose (E464), titanium dioxide (E171), and macrogol 8000 in the film-coating.
Croatian: - Drugi sastojci su: kukuruzni škrob, povidon (E1201), krospovidon (E1202), bezvodni koloidni silicijev dioksid, magnezijev stearat (E470b) i laktoza hidrat u jezgri tablete te talk (E553b), hipromeloza (E464), titanijev dioksid (E171), makrogol 8000 i žuti željezov oksid (E172) u film ovojnici.
English: The long half-life of leflunomide should be considered when contemplating administration of a live attenuated vaccine after stopping Leflunomide Zentiva.
Croatian: Kad se razmatra primjena živih atenuiranih cjepiva nakon prekida liječenja lijekom Leflunomide Zentiva, potrebno je uzeti u obzir dugi poluvijek leflunomida.
English: All of these also resolved, 2 with continuation of both medicinal products and 3 after discontinuation of leflunomide.
Croatian: Sve su se te vrijednosti smanjile, u 2 bolesnika koji su nastavili istodobno uzimati oba lijeka i u 3 bolesnika koji su prekinuli uzimati leflunomid.